Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants.

Luger T, Boguniewicz M, Carr W, Cork M, Deleuran M, Eichenfield L, Eigenmann P, Fölster-Holst R, Gelmetti C, Gollnick H, Hamelmann E, Hebert AA, Muraro A, Oranje AP, Paller AS, Paul C, Puig L, Ring J, Siegfried E, Spergel JM, Stingl G, Taieb A, Torrelo A, Werfel T, Wahn U

Open source

DOI: 10.1111/pai.12331
Published: 2015 Jun
Container: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/pai.12331,
  title = {Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants.},
  author = {Luger T and Boguniewicz M and Carr W and Cork M and Deleuran M and Eichenfield L and Eigenmann P and Fölster-Holst R and Gelmetti C and Gollnick H and Hamelmann E and Hebert AA and Muraro A and Oranje AP and Paller AS and Paul C and Puig L and Ring J and Siegfried E and Spergel JM and Stingl G and Taieb A and Torrelo A and Werfel T and Wahn U},
  year = {2015},
  journal = {Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology},
  doi = {10.1111/pai.12331},
  url = {https://doi.org/10.1111/pai.12331}
}

RIS

TY  - JOUR
TI  - Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants.
AU  - Luger T
AU  - Boguniewicz M
AU  - Carr W
AU  - Cork M
AU  - Deleuran M
AU  - Eichenfield L
AU  - Eigenmann P
AU  - Fölster-Holst R
AU  - Gelmetti C
AU  - Gollnick H
AU  - Hamelmann E
AU  - Hebert AA
AU  - Muraro A
AU  - Oranje AP
AU  - Paller AS
AU  - Paul C
AU  - Puig L
AU  - Ring J
AU  - Siegfried E
AU  - Spergel JM
AU  - Stingl G
AU  - Taieb A
AU  - Torrelo A
AU  - Werfel T
AU  - Wahn U
PY  - 2015
JO  - Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
DO  - 10.1111/pai.12331
UR  - https://doi.org/10.1111/pai.12331
ER  -

APA

T, L., M, B., W, C., M, C., M, D., L, E., P, E., R, F., C, G., H, G., E, H., AA, H., A, M., AP, O., AS, P., C, P., L, P., J, R., E, S., JM, S., G, S., A, T., A, T., T, W., & U, W. (2015). Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants.. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology. https://doi.org/10.1111/pai.12331

Source records

pubmed · retrieved 2026-09-27T09:45:24.664Z